Leukotriene C4 elimination and metabolism in man. 1990

N H Maltby, and G W Taylor, and J M Ritter, and K Moore, and R W Fuller, and C T Dollery
Department of Clinical Pharmacology, Royal Postgraduate Medical School, London, England.

Three doses of radiolabeled leukotriene C4 (0.2 to 15 muCi) were infused into three subjects to investigate its metabolism and routes of elimination during 4 days. Between 12% and 20% of the infused dose was recovered in the urine within 24 hours, of which a substantial and relatively constant proportion (4.1% to 6.3% total dose) appeared as leukotriene E4 (LTE4), mainly in the first 4 hours. Polar omega-oxidation products, N-acetyl LTE4, and tritiated water were also present. Fecal elimination accounted for a further 30% to 40% of the infused dose. In the absence of altered metabolism or biliary excretion, urinary LTE4 may be a useful measure of whole body production of the cysteinyl leukotrienes.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013189 SRS-A A group of LEUKOTRIENES; (LTC4; LTD4; and LTE4) that is the major mediator of BRONCHOCONSTRICTION; HYPERSENSITIVITY; and other allergic reactions. Earlier studies described a "slow-reacting substance of ANAPHYLAXIS" released from lung by cobra venom or after anaphylactic shock. The relationship between SRS-A leukotrienes was established by UV which showed the presence of the conjugated triene. (From Merck Index, 11th ed) Slow Reacting Substance of Anaphylaxis
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014316 Tritium The radioactive isotope of hydrogen also known as hydrogen-3. It contains two NEUTRONS and one PROTON in its nucleus and decays to produce low energy BETA PARTICLES. Hydrogen-3,Hydrogen 3

Related Publications

N H Maltby, and G W Taylor, and J M Ritter, and K Moore, and R W Fuller, and C T Dollery
July 1985, Biochemical and biophysical research communications,
N H Maltby, and G W Taylor, and J M Ritter, and K Moore, and R W Fuller, and C T Dollery
March 1993, Prostaglandins,
N H Maltby, and G W Taylor, and J M Ritter, and K Moore, and R W Fuller, and C T Dollery
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
N H Maltby, and G W Taylor, and J M Ritter, and K Moore, and R W Fuller, and C T Dollery
November 1992, Canadian journal of physiology and pharmacology,
N H Maltby, and G W Taylor, and J M Ritter, and K Moore, and R W Fuller, and C T Dollery
January 1987, Advances in enzyme regulation,
N H Maltby, and G W Taylor, and J M Ritter, and K Moore, and R W Fuller, and C T Dollery
April 1986, Journal of neurochemistry,
N H Maltby, and G W Taylor, and J M Ritter, and K Moore, and R W Fuller, and C T Dollery
May 1989, Prostaglandins, leukotrienes, and essential fatty acids,
N H Maltby, and G W Taylor, and J M Ritter, and K Moore, and R W Fuller, and C T Dollery
January 1997, International journal of clinical & laboratory research,
N H Maltby, and G W Taylor, and J M Ritter, and K Moore, and R W Fuller, and C T Dollery
February 1991, Circulatory shock,
N H Maltby, and G W Taylor, and J M Ritter, and K Moore, and R W Fuller, and C T Dollery
November 1992, Archives of biochemistry and biophysics,
Copied contents to your clipboard!